In summary, evidence is emerging that the aberrant m6A modification of TNFR1 plays important roles in the initiation and progression of ESCC through ATXN2-induced posttranscriptional regulation, which is an important oncogenic mechanism for ESCC. The gene discussed is TNFRSF1A; the disease is esophageal squamous cell carcinoma.